Regenerative Medicine for the benefit of patients
We promote the transfer of knowledge in regenerative medicine and its symbiosis with disruptive technologies, training leaders and professionals with an innovative spirit through our specialized health training.
What is regenerative medicine?
Regenerative medicine is a branch of medicine oriented to the development of treatments against hereditary and degenerative diseases that, until now, lacked a cure. One of the practices used in this area is cell therapy.
What is cell therapy?
Cellular therapy is the introduction of new cells into a tissue with the aim of treating a disease. This type of treatment is used in regenerative medicine, an innovative area with great potential for the future of health and longevity.
Cell therapy seeks to develop new tissues to repair damaged or diseased tissues. This healing practice offers the opportunity for the patient to see their life expectancy increased as well as its quality.
The goal of cell therapy is to restore lost function instead of producing a new organ, which could cause duplication and undesirable effects. Various cell resources can be used to restore damaged tissue, such as resident stem cells, multipotent adult progenitor cells or embryonic stem cells. Some cell therapies have been established and approved for clinical use, such as artificial skin derived from keratinocytes, derived from chondrocytes, corneal limbus cells or pancreatic islet transplantation.
The European Institute’s commitment to regenerative medicine
We are creating a “Center of Excellence” in regenerative medicine and cell therapy, in order to carry out stem cell treatments to clinical practice.
We will promote the stem cell treatments, obtained from bone marrow, which are pluripotential cells, capable of differentiating into different tissues. Its application in certain diseases is based on scientific evidence.
Likewise, we will develop a new approach to some pathologies with mesenchymal stem cells, obtained from abdominal fat, through a small liposuction performed with local anesthesia. They are pluripotential cells and increasingly used in clinical practice.
We will implement procedures with clinical safety to ensure adequate preparation, extraction and cell implantation in a single therapeutic process.
Thus, the commitment of the European Institute for Health and Social Welfare to regenerative medicine is reflected in our commitment to the development of new treatments, technological innovation and the implementation of cutting-edge techniques and methodologies in the field of health, such as cell therapy .
The future of medicine is being approximated by institutions and entities that invest in healing hereditary or degenerative diseases through research, development and innovation applied to regenerative medicine.
“My goals over the decade include to develop new drugs to treat intractable diseases by using iPS cell technology and to conduct clinical trials using it on a few patients with Parkinson’s diseases diabetes or blood diseases.